Stock watch list, 06/12/2013, BPAX, DYSL, HEB,Penny Stocks, DOMK,XIDE,FFFC,GCEI, fresh daily deals & timely tweets, sign-up/follow us

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

FDA's surprise Valentine Gift to WOMEN!

FDA's surprise Valentine Gift to WOMEN!

Who says FDA doesn't know anything about romance? We are pretty sure nothing like this ever happened before, the greatest romantic gesture in the history of FDA and the timing was priceless!

On Valentine eve FDA delivered a surprise gift, Ladies: its NOT long stem Roses, something Better! FDA said YES! to Gel. FDA has approved BioSante's Bio-T-Gel. BPAX estimates the market for Male Dysfunction drugs in the US alone is $1.2 Billion Dollars.

We alerted our members on Jan 17th when the stock was trading near the 52WK Lows, our headline read “BPAX shareholders wonder if there is a Gel for stock dysfunction!”

Well, there you have it, FDA answered the prayers and BPAX is UP a whopping 107% ! our members are ecstatic. Are you Gellin'?

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
we receive compensation from companies we feature, Always Read the full Disclosure/Disclaimer. Thanks.

Improving women's health and sex life, Bionovo, BNVI

Bionovo, BNVI, Profile, Summary
Bionovo (BNVI) a clinical-stage drug discovery and development company, focuses on the development drug candidates in the areas of women's health and cancer. The company's drug development process utilizes botanical sources used in traditional Chinese medicine to produce biologically active compounds.
Bionovo's lead drug candidate, Menerba, which completed phase 2 clinical trail and progressing into phase 3.
Improving Women’s Health
40 million women in America are of menopausal age, an estimated 75% to 85% experience significant and unpleasant side effects due to declining and fluctuating hormone levels. These problems include vaginal dryness, depression and weight gain. Existing therapies represent a multi-billion dollar market. Bionovo is striving to provide a safe, reliable, and clinically proven therapy to fill this unmet need.
The company also develops Bezielle, an oral anti-cancer agent that completed two separate phase 1 clinical trails for the treatment of advanced breast cancer. Seala, a preclinical drug candidate for the treatment of post-menopausal vulvar and vaginal atrophy.
Conquering Cancer
Breast cancer is the second leading cause of cancer deaths in the United States, and more than 200,000 new cases are diagnosed each year. As a result, breast cancer takes more than 40,000 lives annually.
The company successfully raised funds and appointed new executives and board members. The stock is trading near 52WK LOWS could bounce back, keep an eye!
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
we receive compensation from companies we feature. Always Read the full Disclosure/Disclaimer. Thanks.

Female Sexual Dysfunction, FSD

Female Sexual Dysfunction HOW BIG is the problem? And, How common is it? According to a recent study, conducted by the University of Chicago and published in the Journal of the American Medical Association, it apparently is a huge problem. 43% of women (aged 18 to 59) said they have experienced some degree of sexual dysfunction. A SMALL pharmaceutical company wants to change all that and want to level the playing field for Women! BioSante, BPAX, a specialist pharmaceutical company focused on Female health, wants to exploit the huge potential market opportunity. Men spent a whopping $5 Billion Dollars on Erectile Dysfunction drugs in 2011, according to the NY Times. BioSante's answer LibiGel! LibiGel is a transdermal testosterone gel in development for the treatment of Female Sexual Dysfunction – FSD -. BioSante has completed two Phase III LibiGel safety and efficacy trials and is conducting a Phase III cardiovascular event and breast cancer safety study. The company is planning to submit a new drug application to the FDA by year-end 2012. BioSante is an equal opportunity company, at least, when it comes to making money, so the company doesn't want to miss the rising demand from men. For men BioSante is developing, Bio-T-Gel™ , a once-daily transdermal testosterone gel for the treatment of male hypogonadism, or low testosterone levels. Low testosterone affects more than 4 to 5 million men in the U.S, according to the company. Is there are Gel for that? stock holders wish there was one. The Stock fell to the bottom gracelessly, still embarrassed and some what shameful, trading around its 52WK LOWS. We see a short to medium term bounce-back opportunity. Keep an eye. Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!® we receive compensation from companies we feature. Always Read the full Disclosure/Disclaimer. Thanks.

50 Cent Biotech stocks,NASDAQ stocks for a Dollar or LESS

OXGN – OxiGENE is a biopharmaceutical company, develops novel therapeutics to treat cancer and eye diseases. It primarily focuses on the development of vascular disrupting agents (VDAs) that disable and destroy abnormal blood vessels, which provide solid tumors a means of growth and survival, as well as associate with visual impairment in various ophthalmological diseases and conditions.
OXiGENE has several drugs in Phase 1 and Phase II as well as a strategic collaboration agreement with Symphony Capital Partners. Very Attractive, Medium to Long term, keep an eye!

INO - Inovio Pharmaceuticals is developing a DNA vaccines with a focus on cancers and infectious diseases. The company’s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against new, unmatched strains of pathogens, such as influenza. Very Attractive, Keep an Eye!
You are missing the Premium Alerts!Sign-up, Get Alerts that MakeMoney!® we get compensated by the companies we feature. Always Read the full Disclosure/Disclaimer. Thanks

No rambling commentary, No non-sense, Just Picks that make you Money!

Hot Stocks to Watch 08-15-2011
Our Pick MOTR gained a whopping 47% since we alerted you on Thursday! FactCheck
Our picks for Today!

We still Like MOTR , add BPAX and TGS to your list.

NO rambling commentary, NO non-sense. Just Picks that make you Money!
Get Alerts that MakeMoney!® Everything else:HOTair©

Watch these Stocks Today:CNET, China Net, BPAX, Bio Sante

Hot Stock Picks for Friday 07-08-2011

CNET - ChinaNet Online Holdings operates media development and advertising platforms for the small and medium enterprise market in China. Its multi-platform advertising network consists of the Website www.28.com, an Internet advertising portal; ChinaNet TV, a television production and advertising unit; and bank kiosk advertising unit, which is primarily used as an advertising platform for clients in the financial services industry.
Huge Growth potential, Very, Very attractive, must be on your list.

BPAX - BioSante Pharmaceuticals a specialty pharmaceutical company, develops products for female sexual health and oncology. Its lead products include LibiGel for the treatment of female sexual dysfunction (FSD), which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) special protocol assessment; and Elestrin for the treatment of moderate-to-severe vasomotor symptoms associated with menopause.

We Featured this company before, we still love it, very attractive, keep it on your list.

Get Alerts that MakeMoney® Everything else:HOTair©
Remember: We are NOT a Non-Profit organization, we get compensated by the companies we feature on our website(s) Blog(s) News Letters and Email Alerts. Always Read the full Disclosure/Disclaimer. Thanks

Female Sexual Dysfunction, FSD treatment

Hot Stock Picks Friday 05-20-11

Stocks to Watch

TRID - Trident Microsystems provides high-performance multimedia semiconductor solutions for the digital home entertainment market. It designs integrated circuits (ICs), and related software for processing, displaying, and transmitting high quality audio, graphics. Bouncing back from 52WK Lows, keep an eye.

BPAX - BioSante Pharmaceuticals, a specialty pharmaceutical company, develops products for female sexual health and oncology. Its lead products include LibiGel for the treatment of female sexual dysfunction (FSD), which is in Phase III clinical development under (FDA) special protocol assessment. Huge Market potential must be on your watch list.
Get Alerts that MakeMoney!® Everything else:HOTair©